Adcytherix is a clinical‑stage biopharma that creates next‑generation antibody‑drug conjugates (ADCs) by linking clinically validated antibodies to innovative payloads derived from already approved cancer drugs. Their platform uses advanced conjugation chemistry to improve stability, control payload release, and overcome resistance mechanisms, expanding the therapeutic window for high‑unmet‑need solid tumors. The company’s pipeline targets cancers that are refractory to existing ADCs, offering more precise and tolerable oncology therapies.

Air Doctor connects travelers with a global network of verified private doctors for in-person or telemedicine consultations. Patients can easily book appointments with local specialists who speak their language through the digital health platform. This service provides accessible medical care for individuals needing assistance while traveling internationally.

Akoya Biosciences provides high-parameter tissue analysis solutions through its PhenoCode™ Discovery IO60 panel, which enables ultrahigh-plex spatial phenotyping of up to 60 biomarkers in a single sample. This technology facilitates the discovery and validation of biomarkers, enhancing drug development and precision medicine by delivering actionable insights from complex tissue samples.

Alt is a financial services platform that facilitates the investment in alternative assets by providing a marketplace for trading collectibles and sports memorabilia. This approach enables investors to unlock liquidity and value from traditionally illiquid asset classes, addressing the challenge of accessing and monetizing these investments.

Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing small molecule therapeutics to treat specific diseases. Their focus is on advancing targeted therapies that address unmet medical needs in oncology and other therapeutic areas.

Better Life Partners offers medical and behavioral healthcare services, including medication-assisted treatment and therapy, to support individuals recovering from addiction. Their team provides accessible care through in-person and virtual options, ensuring timely support tailored to each person's needs.

BIOS Health develops neural interfaces and AI technology to read and write neural data, enabling real-time analysis of the nervous system's signals. This approach addresses the malfunctioning signals that can lead to diseases, facilitating the creation of targeted pharmaceuticals and software-delivered therapies.

Cavos provides automated quality assurance and real-time coaching for contact centers through AI-driven analysis of 100% of customer interactions, enabling precise performance feedback and compliance monitoring. This technology enhances agent efficiency and customer satisfaction by ensuring consistent service quality and reducing training time.

Character is a precision medicine company focused on macular degeneration and primary open-angle glaucoma, utilizing clinical genomic databases and machine learning to identify genetic drivers of disease progression. By characterizing patient subtypes, Character aims to develop targeted therapies for conditions that currently have limited treatment options.

Connie Health utilizes a technology platform that compares Medicare plans based on individual budget and healthcare needs, enabling older Americans to select the most suitable coverage. The service is provided at no cost to users, as insurance companies compensate Connie Health for facilitating plan enrollments.

Dice is a corporate spend orchestration platform that integrates procurement, accounts payable, and expense management to streamline financial operations for enterprises. By connecting over 500,000 employees and 150,000 vendors, Dice enhances transaction efficiency and compliance, processing $1.5 billion annually while reducing reconciliation time by 0%.

Eleos offers a fully digital platform for embedded life and income protection insurance, allowing customers to purchase policies online in minutes without the need for personal interaction. By providing essential financial security against income loss due to illness or injury, Eleos enables partners to earn revenue through commission while ensuring FCA compliance.

GraphiteRx provides a cloud-based marketplace that consolidates direct pharmaceutical procurement for hospitals, pharmacies, and clinics, enabling them to manage over $500 million in spending on essential medical supplies. This platform reduces costs and improves access to products by streamlining the ordering process and eliminating the inefficiencies associated with traditional wholesale distribution.

H Company develops AI models, including VLMs and LLMs, to automate web processes and enhance decision-making for businesses. Their technology increases worker productivity by streamlining repetitive tasks and improving operational efficiency.

Heal is a nonprofit ecommerce platform that utilizes experience-based peer support to help individuals with mental illness reconnect with their passions through creative expression. By empowering emerging artists to showcase their work, Heal reinvests 100% of its profits into community-building initiatives that foster meaningful connections.

Hopscotch Primary Care delivers accessible, proactive value-based senior primary care specifically to rural communities. The practice focuses on patients covered by Medicare and Medicare/Medicaid plans, providing comprehensive support through a dedicated care team. This model emphasizes building strong patient relationships by dedicating more time and resources to individual healthcare needs.

Iantrek develops microinterventional surgical technologies, including the CycloPen™ and AlloFlo™, designed for precise cyclodialysis and enhanced uveoscleral outflow in glaucoma treatment. These systems address the challenges of traditional glaucoma surgeries by providing controlled, minimally invasive options that improve patient outcomes and reduce recovery times.

This startup develops a payment application that utilizes lightning-infrastructure-as-a-service technology to enable real-time settlement and facilitate cross-border, cross-currency payments through the Bitcoin lightning network. By transforming closed payment ecosystems into open, interoperable systems, the company allows FinTech firms to scale globally while ensuring security and regulatory compliance.

Lin Health provides an evidence-based treatment program for patients suffering from chronic pain conditions. The intervention combines multidisciplinary clinical guidance, high-frequency coaching, and proprietary digital resources targeting nervous system signaling. This approach aims to reduce pain intensity and improve patient function, offering an alternative to opioids for providers and health systems.

The startup develops a proprietary B-Raf inhibitor, a small molecule that enhances the administration of epidermal growth factor receptor (EGFR) inhibitors in cancer therapy. This approach minimizes cutaneous side effects, thereby improving treatment effectiveness and the quality of life for patients undergoing EGFR therapy.

Lyfegen offers a cloud‑based SaaS platform that centralizes drug contracting, rebate analytics, and pricing simulations for health insurers, government payers, hospital networks, and pharmaceutical manufacturers. The solution automates rebate identification, calculation, and claim submission while providing a searchable library of 7,000+ public pricing agreements and a simulator for value‑based contract modeling, helping users capture missed revenue and accelerate patient access.

MDClone provides a self-service data analytics platform, ADAMS, that enables healthcare organizations to explore and analyze patient data securely and independently. This technology facilitates collaboration and research by overcoming data access barriers, ultimately improving patient outcomes and operational efficiencies.

Lo provides a platform for managing and automating commercial real estate leasing workflows. It centralizes lease documentation, tracks key dates, and streamlines communication between landlords and tenants. This system helps commercial property managers reduce administrative overhead and ensure compliance across their portfolio.

Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.